Publication | Open Access

Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer

Hsp90 Inhibition ResultsBreast OncologyMedicinePharmacologyBreast CancerTriple-negative Breast CancerCancer TreatmentOncologyCell BiologyTumor MicroenvironmentEndocrine-related CancerGlucocorticoid Receptor Degradation